CAI Caris Life Sciences, Inc.
P/E
18.93
Forward P/E
38.61
Price/Sales
9.14
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Caris Life Sciences third quarter 2026 revenue beat expectations while full-year guidance was raised
Caris Life Sciences reported third quarter 2026 revenue of $275.4 million, reflecting 27% year-over-year growth and exceeding the analyst estimate of $255.3...
Caris Life Sciences, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Analysts expect Caris Life Sciences to report Q3 2026 revenue of approximately $255.34 million and earnings per share of $0.03, with the stock currently...